Company Biophytis S.A.

Equities

ALBPS

FR0012816825

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Real-time Euronext Paris Other stock markets 10:15:33 2024-04-24 am EDT			5-day change	1st Jan Change
0.0025 ^EUR	0.00%		+8.70%	-50.98%

Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT
Apr. 22	European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	MT

Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.

The company is located in Paris, France and Cambridge, Massachusetts.

Number of employees: 22

Managers	Title	Age	Since
Stanislas Veillet CEO	Chief Executive Officer	58	06-09-14
Nicolas Fellmann DFI	Director of Finance/CFO	55	23-05-21
Claudia Ferreira CTO	Chief Tech/Sci/R&D Officer	-	23-09-13
Rob van Maanen CTO	Chief Tech/Sci/R&D Officer	54	21-09-08
Pierre J. Dilda CTO	Chief Tech/Sci/R&D Officer	54	15-11-30
Waly Dioh CTO	Chief Tech/Sci/R&D Officer	55	06-09-14
Jean Mariani BRD	Director/Board Member	74	19-10-28
Edouard Bieth PRN	Corporate Officer/Principal	44	23-09-13
Chiara Baccelli PRN	Corporate Officer/Principal	48	22-12-31

Members of the board	Title	Age	Since
Nadine Coulm BRD	Director/Board Member	61	15-05-21
Claude Allary BRD	Director/Board Member	69	21-07-06
Stanislas Veillet CEO	Chief Executive Officer	58	06-09-14
Jean Mariani BRD	Director/Board Member	74	19-10-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,040,482,402	422,265,366 ( 40.58 %)	240,026 ( 0.0231 %)	40.58 %

Name	Equities	%	Valuation
Gestys SA 1.953 %	22,380,000	1.953 %	84 596 €
Stanislas Veillet 0.2397 %	2,746,618	0.2397 %	10 382 €
Lyxor International Asset Management SAS 0.0207 %	236,829	0.0207 %	895 €
Ecofi Investissements SA 0.009248 %	105,980	0.009248 %	401 €
Claresco Finance SA 0.002557 %	29,300	0.002557 %	111 €
Waly Dioh 0.002181 %	25,000	0.002181 %	95 €
Nadine Coulm 0.000109 %	1,250	0.000109 %	5 €
Génération Vie SA 0.000035 %	400	0.000035 %	2 €
Allianz Global Investors GmbH (France) 0.000026 %	300	0.000026 %	1 €
Claude Allary 0.000000 %	0	0.000000 %	- €

Name	Equities	%	Valuation
Morgan Stanley & Co. International Plc 0.0401 %	4,600	0.0401 %	1 615 €
RhumbLine Advisers LP 0.004625 %	530	0.004625 %	186 €

Biophytis SA

Sorbonne Université Bâtiment A 4 ème étage

75005, Paris

+33 1 44 27 23 00

http://www.biophytis.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BIOPHYTIS S.A.	-50.98%	3.06M
VERTEX PHARMACEUTICALS INCORPORATED	-0.13%	105B
REGENERON PHARMACEUTICALS, INC.	+4.26%	97.5B
ARGENX SE	+1.98%	22.19B
BIONTECH SE	-15.84%	21.33B
GENMAB A/S	-7.59%	18.68B
WUXI APPTEC CO., LTD.	-41.41%	16.6B
BEIGENE, LTD.	-19.92%	14.52B
NEUROCRINE BIOSCIENCES, INC.	+6.85%	14.09B
SAREPTA THERAPEUTICS, INC.	+22.51%	10.99B

Bio Therapeutic Drugs